Logo image of ENVIP.OL

ENVIPCO HOLDING NV (ENVIP.OL) Stock Fundamental Analysis

Europe - OSL:ENVIP - NL0015000GX8 - Common Stock

81.6 NOK
-0.8 (-0.97%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

ENVIP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Machinery industry. ENVIP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ENVIP is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ENVIP had negative earnings in the past year.
ENVIP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ENVIP reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ENVIP reported negative operating cash flow in multiple years.
ENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ENVIP has a worse Return On Assets (-4.57%) than 79.61% of its industry peers.
The Return On Equity of ENVIP (-8.52%) is worse than 77.67% of its industry peers.
The Return On Invested Capital of ENVIP (0.58%) is worse than 78.64% of its industry peers.
Industry RankSector Rank
ROA -4.57%
ROE -8.52%
ROIC 0.58%
ROA(3y)-2.29%
ROA(5y)-2.04%
ROE(3y)-6.03%
ROE(5y)-4.88%
ROIC(3y)N/A
ROIC(5y)N/A
ENVIP.OL Yearly ROA, ROE, ROICENVIP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ENVIP has a worse Operating Margin (0.56%) than 79.61% of its industry peers.
ENVIP has a Gross Margin (37.69%) which is in line with its industry peers.
ENVIP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.56%
PM (TTM) N/A
GM 37.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.12%
GM growth 5Y-0.13%
ENVIP.OL Yearly Profit, Operating, Gross MarginsENVIP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

ENVIP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ENVIP has been increased compared to 1 year ago.
The number of shares outstanding for ENVIP has been increased compared to 5 years ago.
The debt/assets ratio for ENVIP is higher compared to a year ago.
ENVIP.OL Yearly Shares OutstandingENVIP.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENVIP.OL Yearly Total Debt VS Total AssetsENVIP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ENVIP has an Altman-Z score of 5.28. This indicates that ENVIP is financially healthy and has little risk of bankruptcy at the moment.
ENVIP has a better Altman-Z score (5.28) than 93.20% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ENVIP is not too dependend on debt financing.
The Debt to Equity ratio of ENVIP (0.13) is better than 79.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 5.28
ROIC/WACC0.08
WACC7.38%
ENVIP.OL Yearly LT Debt VS Equity VS FCFENVIP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ENVIP has a Current Ratio of 2.03. This indicates that ENVIP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.03, ENVIP is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
A Quick Ratio of 1.25 indicates that ENVIP should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.25, ENVIP is doing good in the industry, outperforming 71.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.25
ENVIP.OL Yearly Current Assets VS Current LiabilitesENVIP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

ENVIP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.00%.
Looking at the last year, ENVIP shows a very strong growth in Revenue. The Revenue has grown by 30.14%.
Measured over the past years, ENVIP shows a very strong growth in Revenue. The Revenue has been growing by 25.76% on average per year.
EPS 1Y (TTM)-180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)30.14%
Revenue growth 3Y43.67%
Revenue growth 5Y25.76%
Sales Q2Q%-13.22%

3.2 Future

The Earnings Per Share is expected to grow by 308.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, ENVIP will show a very strong growth in Revenue. The Revenue will grow by 42.56% on average per year.
EPS Next Y202%
EPS Next 2Y584.69%
EPS Next 3Y308.77%
EPS Next 5YN/A
Revenue Next Year26.53%
Revenue Next 2Y49.61%
Revenue Next 3Y42.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENVIP.OL Yearly Revenue VS EstimatesENVIP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENVIP.OL Yearly EPS VS EstimatesENVIP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ENVIP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 15.69, ENVIP is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as ENVIP.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, ENVIP is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.69
ENVIP.OL Price Earnings VS Forward Price EarningsENVIP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

ENVIP's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. ENVIP is more expensive than 81.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 43.64
ENVIP.OL Per share dataENVIP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ENVIP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ENVIP's earnings are expected to grow with 308.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y584.69%
EPS Next 3Y308.77%

0

5. Dividend

5.1 Amount

No dividends for ENVIP!.
Industry RankSector Rank
Dividend Yield N/A

ENVIPCO HOLDING NV

OSL:ENVIP (9/19/2025, 7:00:00 PM)

81.6

-0.8 (-0.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners34.78%
Inst Owner ChangeN/A
Ins Owners35.17%
Ins Owner ChangeN/A
Market Cap4.71B
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.1%
Min EPS beat(2)-75.49%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-101.06%
Min EPS beat(4)-149.02%
Max EPS beat(4)-30.72%
EPS beat(8)3
Avg EPS beat(8)-46.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.69%
Min Revenue beat(2)-24.86%
Max Revenue beat(2)7.48%
Revenue beat(4)1
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-24.86%
Max Revenue beat(4)7.48%
Revenue beat(8)3
Avg Revenue beat(8)-2.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-92.86%
EPS NY rev (3m)-92.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.95%
Revenue NY rev (1m)-4.61%
Revenue NY rev (3m)-4.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.69
P/S 3.78
P/FCF N/A
P/OCF N/A
P/B 6.31
P/tB 8.17
EV/EBITDA 43.64
EPS(TTM)-0.93
EYN/A
EPS(NY)5.2
Fwd EY6.37%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS21.61
BVpS12.92
TBVpS9.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -8.52%
ROCE 0.76%
ROIC 0.58%
ROICexc 0.78%
ROICexgc 1.04%
OM 0.56%
PM (TTM) N/A
GM 37.69%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-2.04%
ROE(3y)-6.03%
ROE(5y)-4.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.12%
GM growth 5Y-0.13%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.91
Cap/Depr 102.82%
Cap/Sales 8.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.25
Altman-Z 5.28
F-Score5
WACC7.38%
ROIC/WACC0.08
Cap/Depr(3y)135.02%
Cap/Depr(5y)123.96%
Cap/Sales(3y)10.49%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y202%
EPS Next 2Y584.69%
EPS Next 3Y308.77%
EPS Next 5YN/A
Revenue 1Y (TTM)30.14%
Revenue growth 3Y43.67%
Revenue growth 5Y25.76%
Sales Q2Q%-13.22%
Revenue Next Year26.53%
Revenue Next 2Y49.61%
Revenue Next 3Y42.56%
Revenue Next 5YN/A
EBIT growth 1Y-89.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.56%
EBIT Next 3Y142.35%
EBIT Next 5YN/A
FCF growth 1Y63.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.44%
OCF growth 3YN/A
OCF growth 5YN/A